Samalin Investment Counsel LLC Takes $218,000 Position in HCA Healthcare, Inc. $HCA

Key Points

• Samalin Investment Counsel LLC purchased 631 shares of HCA Healthcare, valued at approximately $218,000, in the first quarter of the year, according to its SEC filing.
• HCA Healthcare reported $6.84 earnings per share for the last quarter, exceeding analyst expectations, with revenues reaching $18.61 billion, up 6.4% year-over-year.
• The company recently declared a quarterly dividend of $0.72 per share, which will be paid on September 30th, reflecting a 0.7% yield on an annualized basis.

Samalin Investment Counsel LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 631 shares of the company's stock, valued at approximately $218,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HCA. Brighton Jones LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $1,021,000. Boothbay Fund Management LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $786,000. Kapitalo Investimentos Ltda purchased a new position in HCA Healthcare in the fourth quarter valued at $147,000. Darsana Capital Partners LP boosted its holdings in HCA Healthcare by 6.5% in the fourth quarter. Darsana Capital Partners LP now owns 1,225,000 shares of the company's stock valued at $367,684,000 after purchasing an additional 75,000 shares during the period. Finally, Aptus Capital Advisors LLC boosted its holdings in HCA Healthcare by 1,093.7% in the fourth quarter. Aptus Capital Advisors LLC now owns 27,228 shares of the company's stock valued at $8,172,000 after purchasing an additional 24,947 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HCA. Cantor Fitzgerald reiterated an "overweight" rating and issued a $444.00 target price on shares of HCA Healthcare in a report on Tuesday. Robert W. Baird lifted their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Wells Fargo & Company decreased their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a research report on Thursday, August 14th. Finally, Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Stock Performance

HCA traded down $3.17 on Friday, hitting $404.11. 996,401 shares of the company traded hands, compared to its average volume of 1,129,223. The company has a 50 day moving average of $376.92 and a 200-day moving average of $356.64. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The stock has a market capitalization of $94.56 billion, a PE ratio of 16.99, a PEG ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the prior year, the business earned $5.50 EPS. The firm's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.